Australia markets open in 6 hours 49 minutes

Helius Medical Technologies, Inc. (HSDT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3654-0.0046 (-0.34%)
As of 12:55PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.47M
Enterprise value -126.09k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.38
Price/book (mrq)1.75
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.61
52-week change 3-82.88%
S&P500 52-week change 328.04%
52-week high 314.4500
52-week low 31.3210
50-day moving average 34.5370
200-day moving average 36.6681

Share statistics

Avg vol (3-month) 3555.68k
Avg vol (10-day) 3507.75k
Shares outstanding 52.53M
Implied shares outstanding 62.53M
Float 8884.71k
% held by insiders 10.20%
% held by institutions 12.61%
Shares short (30 Apr 2024) 464.14k
Short ratio (30 Apr 2024) 40.22
Short % of float (30 Apr 2024) 48.00%
Short % of shares outstanding (30 Apr 2024) 47.22%
Shares short (prior month 28 Mar 2024) 472.19k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 304 Jan 2021
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 317 Aug 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,676.12%

Management effectiveness

Return on assets (ttm)-61.40%
Return on equity (ttm)-168.55%

Income statement

Revenue (ttm)644k
Revenue per share (ttm)1.06
Quarterly revenue growth (yoy)-52.50%
Gross profit (ttm)N/A
EBITDA -12.11M
Net income avi to common (ttm)-8.85M
Diluted EPS (ttm)-14.5600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.18M
Total cash per share (mrq)5.84
Total debt (mrq)57k
Total debt/equity (mrq)2.43%
Current ratio (mrq)3.96
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)-10.42M
Levered free cash flow (ttm)-6.11M